Agios Pharmaceuticals, Inc.
AGIO
Revenue
8.96M
▲349.00k▲4.05%
3 Months ChangeAssets
1.79B
▲1.02B▲131.78%
3 Months ChangeLiabilities
165.12M
▲52.57M▲46.71%
3 Months ChangeFree Cash Flow
-100.01M
▼-4.43M▼-4.63%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-31
Form 10-Q
ID: 0001439222-24-000138
2024-10-31
Form 8-K
ID: 0001439222-24-000136
2024-08-01
Form 10-Q
ID: 0001439222-24-000121
2024-08-01
Form 8-K
ID: 0001439222-24-000117
2024-06-20
Form 8-K
ID: 0001193125-24-164555
2024-05-28
Form 8-K
ID: 0001193125-24-147583
2024-05-02
Form 10-Q
ID: 0001439222-24-000069
2024-05-02
Form 8-K
ID: 0001439222-24-000067
2024-02-15
Form 8-K
ID: 0001439222-24-000032
2024-01-08
Form 8-K
ID: 0001193125-24-003920